GENAZZANI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 21.749
AS - Asia 9.149
EU - Europa 8.782
SA - Sud America 1.278
AF - Africa 173
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 4
Totale 41.165
Nazione #
US - Stati Uniti d'America 21.565
GB - Regno Unito 3.509
SG - Singapore 3.088
CN - Cina 2.977
IT - Italia 1.500
HK - Hong Kong 1.286
BR - Brasile 1.055
SE - Svezia 854
DE - Germania 728
UA - Ucraina 588
TR - Turchia 448
VN - Vietnam 425
RU - Federazione Russa 401
FI - Finlandia 368
KR - Corea 242
BG - Bulgaria 226
IN - India 124
FR - Francia 120
ID - Indonesia 95
AR - Argentina 88
NL - Olanda 81
CA - Canada 76
ES - Italia 74
MX - Messico 74
IE - Irlanda 66
PK - Pakistan 57
ZA - Sudafrica 57
JP - Giappone 56
PL - Polonia 54
IQ - Iraq 53
BD - Bangladesh 44
IR - Iran 44
LT - Lituania 38
EC - Ecuador 37
EG - Egitto 34
AU - Australia 28
MA - Marocco 27
RO - Romania 25
BE - Belgio 20
PH - Filippine 20
AT - Austria 19
MY - Malesia 19
AE - Emirati Arabi Uniti 18
PE - Perù 18
IL - Israele 17
SA - Arabia Saudita 17
VE - Venezuela 17
CO - Colombia 16
UY - Uruguay 16
CL - Cile 15
UZ - Uzbekistan 15
PT - Portogallo 14
CZ - Repubblica Ceca 13
PY - Paraguay 13
AZ - Azerbaigian 12
KZ - Kazakistan 12
HU - Ungheria 11
JO - Giordania 11
KG - Kirghizistan 11
GR - Grecia 10
KE - Kenya 10
CH - Svizzera 9
TN - Tunisia 9
AL - Albania 8
GH - Ghana 8
DZ - Algeria 7
PA - Panama 7
NP - Nepal 6
RS - Serbia 6
CR - Costa Rica 5
EE - Estonia 5
LB - Libano 5
NG - Nigeria 5
TH - Thailandia 5
TW - Taiwan 5
YE - Yemen 5
DO - Repubblica Dominicana 4
GE - Georgia 4
HN - Honduras 4
MD - Moldavia 4
NO - Norvegia 4
OM - Oman 4
PS - Palestinian Territory 4
SM - San Marino 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
BO - Bolivia 3
EU - Europa 3
KH - Cambogia 3
LK - Sri Lanka 3
LV - Lettonia 3
MK - Macedonia 3
MN - Mongolia 3
MT - Malta 3
NI - Nicaragua 3
SI - Slovenia 3
SN - Senegal 3
TZ - Tanzania 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
Totale 41.130
Città #
Southend 2.535
Fairfield 2.494
Santa Clara 2.052
Singapore 1.798
Ashburn 1.703
Woodbridge 1.618
Hong Kong 1.274
Houston 1.272
Jacksonville 1.186
Hefei 1.131
Chandler 1.040
Seattle 914
Wilmington 847
Ann Arbor 772
Cambridge 751
Dearborn 679
London 588
Nyköping 534
Beijing 498
Chicago 401
Los Angeles 382
Modena 334
Princeton 242
San Diego 237
Seoul 231
Sofia 222
Buffalo 206
Eugene 193
The Dalles 184
Council Bluffs 177
Izmir 168
Salt Lake City 158
Ho Chi Minh City 157
Helsinki 136
Munich 117
Moscow 109
Shanghai 102
Hanoi 98
São Paulo 90
Des Moines 87
Milan 84
New York 79
Columbus 74
Dallas 73
Elk Grove Village 73
Bremen 67
Redwood City 66
Tampa 65
Dublin 64
San Jose 63
Bologna 62
Rome 62
Jakarta 54
Kent 50
Boardman 49
Guangzhou 45
Norwalk 43
Turku 41
Frankfurt am Main 40
Istanbul 38
Falls Church 37
Rio de Janeiro 36
Tokyo 34
Lancaster 32
Phoenix 32
Sterling 32
Detroit 31
Warsaw 29
Philadelphia 28
Redondo Beach 27
Belo Horizonte 25
Johannesburg 25
Kunming 25
Brooklyn 24
Dongguan 24
Miami 24
Brasília 23
Kilburn 23
Parma 23
Orem 22
Amsterdam 20
Atlanta 20
Boston 20
Dulles 20
Haiphong 20
Mumbai 20
Verona 20
Mexico City 19
Baghdad 18
Chiswick 18
Hounslow 18
Montreal 18
San Mateo 18
Stockholm 18
Cairo 17
Florence 17
Jinan 17
Naples 17
Brussels 16
Curitiba 16
Totale 29.832
Nome #
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea 631
Effects of a Combination of Alpha Lipoic Acid and Myo-Inositol on Insulin Dynamics in Overweight/Obese Patients with PCOS. 425
Inositol as putative integrative treatment for PCOS 375
Hypothalamic amenorrhea: from diagnosis to therapeutical approach. 354
Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback 350
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 332
Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly ? 319
Validation of italian version of the Women's Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers 313
One-year therapy with 10 mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu 301
Neuroendocrine changes in luteal function in patients with premenstrual syndrome. 298
Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. 297
Acetyl-L-Carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea 290
Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia 289
Life events impact in patients with secondary amenorrhoea. 286
Diagnostic and therapeutic approach to hypothalamic amenorrhea 278
Effect of a 2-month treatment with Klamin®, a Klamath algae extract, on the general well-being, antioxidant profile and oxidative status of postmenopausal women 273
Use of metformin in the treatment of polycystic ovary syndrome 272
Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. 268
Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients 267
Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women 263
Acute infusion of naloxone, an opioid receptor antagonist, does not modify serum leptin concentrations in amenorrheic and healthy women 262
Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients 258
Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients 257
Estriol administration modulates luteinizing hormone secretion in women with functional hypothalamic amenorrhea 255
Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling 251
Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome 251
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome 250
Inositol and human reproduction. From cellular metabolism to clinical use 245
Effetto degli estratti di alga Klamath sul benessere e sui fenomeni di stress ossidativo nelle pazienti in menopausa 244
Dall'uso del solo DHEA alla sua associazione con la terapia ormonale sostitutiva 241
Advances in neurosteroids: Role in clinical practice 239
Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle 238
Allopregnanolone concentrations and premenstrual syndrome 236
Color Doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome 235
Estimation of instantaneous secretory rates and intrinsic characteristics of luteinizing hormone secretion in women with Kallmann syndrome before and after estriol administration. 235
Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets 232
A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program. 231
Modulatory effects of l-carnitine plus l-acetyl-carnitine on neuroendocrine control of hypothalamic functions in functional hypothalamic amenorrhea (FHA) 229
La Sindrome Premestruale: clinica, fisiopatologia e indicazioni terapeutiche 228
Actin Cytoskeleton Remodelling by Sex Steroids in Neurones 228
The relevance of inositols treatment for PCOS before and during ART 228
Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers 227
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. 227
Obesità e benessere: i rischi per la salute della donna obesa 226
Short-term estriol administration modulates hypothalamo-pituitary function in patients with functional hypothalamic amenorrhea (FHA) 224
Episodic secretion of activin A in pregnant women 222
Changes in Dopaminergic control of circulating melanocyte- stimulating hormone-related peptides at puberty. 218
Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution 217
EFFECT OF CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN ON PROSTAGLANDIN RELEASE FROM CULTURED MATERNAL DECIDUA AND ON CONTRACTILE ACTIVITY OF HUMAN MYOMETRIUM IN-VITRO 214
PULSATILE SECRETION OF GONADOTROPINS AND PROLACTIN DURING THE FOLLICULAR AND LUTEAL PHASES OF THE MENSTRUAL-CYCLE - ANALYSIS OF INSTANTANEOUS SECRETION RATE AND SECRETORY CONCOMITANCE 210
Adrenal function under long-term raloxifene administration 210
Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS 210
FSH SECRETORY PATTERN AND DEGREE OF CONCORDANCE WITH LH IN AMENORRHEIC, FERTILE, AND POSTMENOPAUSAL WOMEN. 209
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause 206
Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders 204
Effects of Klamath Algae extract on psychological disorders and depression in menopausal women: a pilot study 201
Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. 201
Assessment of the QoL in Italian menopausal women: Comparison between HRT users and non-users 201
The role of color doppler imaging in the diagnosis of polycystic ovary syndrome 201
Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance 201
Effects of estetrol on migration and invasion inT47-D breast cancer cells through the actin cytoskeleton 199
Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. 198
Effects of red clover extracts on breast cancer cell migration and invasion 198
Dydrogesterone exerts endothelial anti-inflammatory actions decreasing expression of leukocyte adhesion molecules 198
Color Doppler analysis in lean and obese women with polycystic ovary syndrome. 198
Color Doppler hysterosalpingography in the diagnosis of tubal patency. 197
. Opioid control of gonadotrophin secretion in humans. 197
Progestinici e fibromatosi uterina 196
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia 196
Which form of HRT should we choose? 195
Melatonin treatment delays reproductive aging of female rat via the opiatergic system. 195
Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1) 195
Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome 195
Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea 194
Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women 194
Effects of cyproheptadine clorhydrate, a serotonin receptor antagonist, on endocrine parameters in weight-loss related amenorrhea 194
Bollettino di Endocrinologia Ginecologica 193
Progestins modulate the action of estrogen on gonadotropin-releasing hormone, luteinizing hormone and prolactin in the rat. 192
Female precocious puberty, obesity and polycystic-like ovaries 191
The duration of prolactin secretory bursts from the pituitary is independent from both prolactin and gonadal steroid plasma levels in women and in men 190
Neuromodulatory role of opioidergic system on hypothalamus-pituitary-gonadal axis during puberty 189
Estrogen replacement therapy modulates spontaneous GH secretion but does not affect GH-RH-induced GH response and low T3 syndrome in women with hypothalamic amenorrhea associated to weight-loss 189
Acetyl-L-Carnitine effect on pituitary and plasma *-endorphin responsiveness to different chronic intermittent stressors. 189
Hypothalamic amenorrhea in a Camurati-Engelmann disease-a case report 188
FREQUENCY OF PROLACTIN PULSATILE RELEASE IN NORMAL MEN AND IN AGONADAL PATIENTS IS NEITHER COUPLED TO LH-RELEASE NOR INFLUENCED BY ANDROGEN MODULATION 188
Effect of short term sibutramine on gonadotropin spontaneous pulsatile release in normogonadotropinemic amenorrheic subjects 188
DHEA as a putative replacement therapy in the elderly 186
Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications 185
Surgical technique of endometrioma excision impacts on the ovarian reserve. Single-port access laparoscopy versus multiport access laparoscopy: a case control study 183
Corticotropin-releasing factor-binding protein: Origins and possible functions 183
Endocrinologia Ginecologica 181
Aspetti endocrini, diagnostici e terapeutici delle menimetrorragie in età perimenopausale. 181
Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women 180
Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome 178
Hypothalamic amenorrhea: Neuroendocrine mechanisms / stress-induced anomalies 177
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea 177
Estetrol modulates endothelial nitric oxide synthesis in human endothelial cells 176
Conjugated equine estrogens reverse the effects of aging on central and peripheral allopregnanolone and beta-endorphin levels in female rats. 175
Polycystic ovary syndrome: A new ultrasonographic and color Doppler pattern 173
Sterss nel paziente odontoiatrico 172
Totale 23.126
Categoria #
all - tutte 178.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.407


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.576 0 0 0 0 0 297 392 723 131 572 218 243
2021/20223.487 66 595 353 284 66 116 279 200 355 217 546 410
2022/20233.192 360 282 178 272 396 518 57 285 429 45 154 216
2023/20242.352 93 145 144 152 558 205 248 326 36 74 147 224
2024/20258.093 334 106 80 620 1.540 1.033 358 490 1.091 744 782 915
2025/20268.636 1.059 725 1.632 1.677 2.214 1.329 0 0 0 0 0 0
Totale 41.500